[Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D005965:Glucuronates / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008875:Middle Aged
D000924:Anticholesteremic Agents; D005965:Glucuronates; D006025:Glycosaminoglycans; D008055:Lipids
Ricerche cliniche nell'individuo anziano sull'effetto antisclerotico di un nuovo eparinoide estrattivo: II. Glicuronilglucosaminglicano solfato (3GS)